Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Single Arm Phase II Study of Single Agent Palifosfamide in Recurrent and Incurable Germ Cell Tumors

NCT01808534 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT01808534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Single Arm Phase II Study of Single Agent Palifosfamide in Recurrent and Incurable Germ Cell Tumors
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2013
Completion date
November 30, 2014
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adult central nervous system germ cell tumor, adult teratoma, extragonadal seminoma, malignant extragonadal germ cell tumor, malignant extragonadal non-seminomatous germ cell tumor, recurrent malignant testicular germ cell tumor, recurrent ovarian germ cell tumor, stage iv extragonadal non-seminomatous germ cell tumor, stage iv extragonadal seminoma, stage iv ovarian germ cell tumor